Severity and mortality of COVID-19 in patients with systemic sclerosis: a Brazilian multicenter study-Reference-Cited by-同舟云学术

Severity and mortality of COVID-19 in patients with systemic sclerosis: a Brazilian multicenter study

Published:2022-08 Issue: Volume:55 Page:151987
ISSN:0049-0172
Container-title:Seminars in Arthritis and Rheumatism
language:en
Short-container-title:Seminars in Arthritis and Rheumatism

Author:

de Oliveira Sandra Maximiano,Martins Lucas Victória de Oliveira,Lupino-Assad Ana Paula,Medeiros-Ribeiro Ana Cristina,de Moraes Daniela Aparecida,Del-Rio Ana Paula Toledo,Oliveira Maria Carolina^ORCID,Sampaio-Barros Percival Degrava^ORCID,Kayser Cristiane^ORCID

Publisher

Elsevier BV

Subject

Anesthesiology and Pain Medicine,Rheumatology

Reference47 articles.

1. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): a review;Wiersinga;JAMA,2020

2. Baseline characteristics and outcome of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy;Grasseli;JAMA,2020

3. SARS-CoV-2 infection in patients with systemic autoimmune diseases;Brito-Zéron;Clin Exp Rheumatol,2021

4. Severity of COVID-19 and survival in patients with rheumatic and inflammatory disease: data from the French RMD COVID-19 cohort of 694 patients;Ann Rheum Dis,2020

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficiency of continuous positive airway pressure and high-flow nasal oxygen therapy in critically ill patients with COVID-19;Journal of International Medical Research;2024-01

2. SARS-CoV-2 spike protein accelerates systemic sclerosis by increasing inflammatory cytokines, Th17 cells, and fibrosis;Journal of Inflammation;2023-12-21

3. Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase;Journal of Translational Autoimmunity;2023-12

4. Outcomes in systemic sclerosis patients hospitalized with COVID-19: Insight from the National Inpatient Sample;Journal of Scleroderma and Related Disorders;2023-11-21

5. Systematic review and meta-analysis of anti-CD20 treatments in patients with COVID-19: an assessment of severe illness and mortality outcomes;Inflammopharmacology;2023-10-07